Iovance Biotherapeutics (IOVA) Non-Current Assets (2009 - 2026)
Iovance Biotherapeutics (IOVA) recorded Non-Current Assets of $451.27 million in Q2 2026, down 6.9% from $484.94 million a year earlier and down 1.7% from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Iovance Biotherapeutics reported Non-Current Assets of $470.48 million, up 3.8% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of 28.9% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $453.41 million in FY2024 (-4.0%), $472.5 million in FY2023 (+155.6%), $184.87 million in FY2022 (-31.4%) and $269.38 million in FY2021 (+103.5%).
- The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q1 2023.
- On a year-over-year basis, Non-Current Assets rose in two of the last five quarters, with an average decline of 2.5%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 318.7% in Q3 2021, against a decline of 31.4% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $459.16 million (Q1 2026), $470.48 million (Q4 2025) and $475.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Iovance Biotherapeutics | 3.74 Bn | 2.45 Bn | 73.44 Mn | 4.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.48 Mn |
| Jun 30, 2026 | 6.43 Mn |
| Mar 31, 2026 | 8.29 Mn |
| Dec 31, 2025 | 8.17 Mn |
| Sep 30, 2025 | 9.27 Mn |
| Jun 30, 2025 | 10.32 Mn |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | 369,000.00 |
| Sep 30, 2024 | 280,000.00 |
| Jun 30, 2024 | 327,000.00 |
| Mar 31, 2024 | 259,000.00 |
| Dec 31, 2023 | 270,000.00 |
| Sep 30, 2023 | 282,000.00 |
| Jun 30, 2023 | 294,000.00 |
| Mar 31, 2023 | 202,000.00 |
| Dec 31, 2022 | 189,000.00 |
| Sep 30, 2022 | 596,000.00 |
| Jun 30, 2022 | 856,000.00 |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 1.78 Mn |
API Access
Iovance Biotherapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();